These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26160883)

  • 1. Participation in Cancer Pharmacogenomic Studies: A Study of 8456 Patients Registered to Clinical Trials in the Cancer and Leukemia Group B (Alliance).
    Dressler LG; Deal AM; Owzar K; Watson D; Donahue K; Friedman PN; Ratain MJ; McLeod HL
    J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26160883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparities in Clinical Trial Participation: A Cross-Sectional Survey of Cancer Patients at a Midwest Academic Medical Center.
    Moreland K; Butsch Kovacic M; Rai S; Sohal D
    Curr Oncol; 2024 Sep; 31(9):5367-5373. PubMed ID: 39330024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of CALGB 9343 Trial and Sociodemographic Variation on Patterns of Adjuvant Radiation Therapy Practice for Elderly Women (≥70 Years) with Stage I, Estrogen Receptor-positive Breast Cancer: Analysis of the National Cancer Data Base.
    Chu QD; Zhou M; Medeiros KL; Peddi P; Wu XC
    Anticancer Res; 2017 Oct; 37(10):5585-5594. PubMed ID: 28982874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities.
    Stewart JH; Bertoni AG; Staten JL; Levine EA; Gross CP
    Ann Surg Oncol; 2007 Dec; 14(12):3328-34. PubMed ID: 17682824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower trial participation by culturally and linguistically diverse (CALD) cancer patients is largely due to language barriers.
    Smith A'; Agar M; Delaney G; Descallar J; Dobell-Brown K; Grand M; Aung J; Patel P; Kaadan N; Girgis A
    Asia Pac J Clin Oncol; 2018 Feb; 14(1):52-60. PubMed ID: 29083094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of migrancy on cancer clinical trial participation: Factors associated with approach and consent in Australian-born versus migrant groups.
    Lim BT; Butow P; Sze ML; Girgis A; Jefford M; Goldstein D; Costa D
    Asia Pac J Clin Oncol; 2020 Jun; 16(3):115-122. PubMed ID: 31957344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geographic proximity and racial disparities in cancer clinical trial participation.
    Kanarek NF; Tsai HL; Metzger-Gaud S; Damron D; Guseynova A; Klamerus JF; Rudin CM
    J Natl Compr Canc Netw; 2010 Dec; 8(12):1343-51. PubMed ID: 21147901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of Participation in Patient-Reported Outcomes and Electronic Data Capture Components of NRG Oncology Clinical Trials.
    Pugh SL; Rodgers JP; Yeager KA; Chen RC; Movsas B; Bonanni R; Dignam J; Bruner DW
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):950-959. PubMed ID: 32590048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why African Americans say "No": A Study of Pharmacogenomic Research Participation.
    Nooruddin M; Scherr C; Friedman P; Subrahmanyam R; Banagan J; Moreno D; Sathyanarayanan M; Nutescu E; Jeyaram T; Harris M; Zhang H; Rodriguez A; Shaazuddin M; Perera M; Tuck M;
    Ethn Dis; 2020; 30(Suppl 1):159-166. PubMed ID: 32269457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparity in Clinical Trial Participation Among Patients with Gastrointestinal Cancer.
    Abbas A; Diaz A; Obeng-Gyasi S; Cloyd JM; Ejaz A; Stewart JH; Pawlik TM
    J Am Coll Surg; 2022 Apr; 234(4):589-598. PubMed ID: 35290279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study.
    Borden BA; Galecki P; Wellmann R; Danahey K; Lee SM; Patrick-Miller L; Sorrentino MJ; Nanda R; Koyner JL; Polonsky TS; Stadler WM; Mulcahy C; Kavitt RT; Ratain MJ; Meltzer DO; O'Donnell PH
    Pharmacogenet Genomics; 2019 Feb; 29(2):31-38. PubMed ID: 30531377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient income level and cancer clinical trial participation.
    Unger JM; Hershman DL; Albain KS; Moinpour CM; Petersen JA; Burg K; Crowley JJ
    J Clin Oncol; 2013 Feb; 31(5):536-42. PubMed ID: 23295802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "When Offered to Participate": A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials.
    Unger JM; Hershman DL; Till C; Minasian LM; Osarogiagbon RU; Fleury ME; Vaidya R
    J Natl Cancer Inst; 2021 Mar; 113(3):244-257. PubMed ID: 33022716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participation in cancer clinical trials: why are patients not participating?
    Byrne MM; Tannenbaum SL; Glück S; Hurley J; Antoni M
    Med Decis Making; 2014 Jan; 34(1):116-26. PubMed ID: 23897588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altruism among participants in cancer clinical trials.
    Truong TH; Weeks JC; Cook EF; Joffe S
    Clin Trials; 2011 Oct; 8(5):616-23. PubMed ID: 21813584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decision Aids Can Support Cancer Clinical Trials Decisions: Results of a Randomized Trial.
    Politi MC; Kuzemchak MD; Kaphingst KA; Perkins H; Liu J; Byrne MM
    Oncologist; 2016 Dec; 21(12):1461-1470. PubMed ID: 27511904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial participation among patients enrolled in the Glioma Outcomes Project.
    Chang SM; Barker FG; Schmidt MH; Sloan AE; Kasper R; Phillips L; Shih K; Hariharan S; Berger MS
    Cancer; 2002 May; 94(10):2681-7. PubMed ID: 12173337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participation in pediatric oncology research protocols: Racial/ethnic, language and age-based disparities.
    Aristizabal P; Singer J; Cooper R; Wells KJ; Nodora J; Milburn M; Gahagan S; Schiff DE; Martinez ME
    Pediatr Blood Cancer; 2015 Aug; 62(8):1337-44. PubMed ID: 25755225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Race, gender, drug use, and participation in AIDS clinical trials. Lessons from a municipal hospital cohort.
    Stone VE; Mauch MY; Steger K; Janas SF; Craven DE
    J Gen Intern Med; 1997 Mar; 12(3):150-7. PubMed ID: 9100139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer trial enrollment after state-mandated reimbursement.
    Gross CP; Murthy V; Li Y; Kaluzny AD; Krumholz HM
    J Natl Cancer Inst; 2004 Jul; 96(14):1063-9. PubMed ID: 15265967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.